Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-small Cell Lung Cancer Metastatic × sintilimab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 13 Stomach Neoplasms 11 Colorectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Neoplasms 2 Endometrial Neoplasms 2 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Resectable NSCLC 1 Recurrence 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Nasopharyngeal Carcinoma 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1

Interventions

tusamitamab ravtansine 2 pembrolizumab 1 dacomitinib 1 Ramucirumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡